Adrenal Liquescence Glycyrrhiza Glabra, Rosa Canina, Aralia Quinquefolia (American Ginseng), Glandula Suprarenalis (Bovine), Adrenalinum, Ephedra Vulgaris, Natrum Muriaticum, Zincum Metallicum, Adrenocorticotrophin 2 [hp_X]/mL; 3 [hp_X]/mL; 3 [hp_X]/mL; 6 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mL Liquid, 120 mL — NDC 83027-0014-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Adrenal Liquescence Glycyrrhiza Glabra, Rosa Canina, Aralia Quinquefolia (American Ginseng), Glandula Suprarenalis (Bovine), Adrenalinum, Ephedra Vulgaris, Natrum Muriaticum, Zincum Metallicum, Adrenocorticotrophin 2 [hp_X]/mL; 3 [hp_X]/mL; 3 [hp_X]/mL; 6 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mL Liquid, 120 mL — NDC 83027-0014-1 (Billing 83027-0014-01)

by Nutritional Specialties, Inc. · 120 mL in 1 BOTTLE, GLASS

This is a package of 120 mL of Adrenal Liquescence Glycyrrhiza Glabra, Rosa Canina, Aralia Quinquefolia (American Ginseng), Glandula Suprarenalis (Bovine), Adrenalinum, Ephedra Vulgaris, Natrum Muriaticum, Zincum Metallicum, Adrenocorticotrophin 2 [hp_X]/mL; 3 [hp_X]/mL; 3 [hp_X]/mL; 6 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mL Liquid from Nutritional Specialties, Inc., marketed since Feb 2023 and currently FDA-listed, this package's marketing is listed to end Sep 2028. It is this product's only package size.

NDC 83027-0014-01
🏷️ FDA NDC (as labeled) 83027-0014-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 83027-0014-1 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
83027 labeler · 0014 product · 1 package
Package marketed since
Feb 21, 2023
Package marketing ended
Sep 20, 2028
Sample package
No — commercial package
Barcode (UPC)
0649818020017
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 83027-0014-1
Product NDC 83027-0014
11-digit billing NDC 83027001401
UNII 2788Z9758H, 3TNW8D08V3, 8W75VCV53Q, M2776SWB29, YKH834O4BH, R55VQ87DP3 +3 more
UPC 0649818020017
SPL Set ID 9f8e7917-33df-4059-9ae9-e3d2fbb8e319
Established class (EPC) Non-Standardized Food Allergenic Extract; Non-Standardized Plant Allergenic Extract; alpha-Adrenergic Agonist; beta-Adrenergic Agonist; Catecholamine; Adrenocorticotropic Hormone
Mechanism of action Adrenergic alpha-Agonists; Adrenergic beta-Agonists
Physiologic effect Increased Histamine Release; Cell-mediated Immunity
Chemical class Allergens; Dietary Proteins; Plant Proteins; Catecholamines; Adrenocorticotropic Hormone
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-02-21
Marketing end 2028-09-20
Route ORAL
Dosage form LIQUID
Substance GLYCYRRHIZA GLABRA; ROSA CANINA FRUIT; AMERICAN GINSENG; BOS TAURUS ADRENAL GLAND; EPINEPHRINE; EPHEDRA DISTACHYA FLOWERING TWIG; SODIUM CHLORIDE; ZINC; CORTICOTROPIN
Why two NDCs? The FDA registers this code as 83027-0014-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 83027-0014-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

Adrenal Liquescence is an unapproved homeopathic liquid product taken by mouth. It contains multiple ingredients, including bovine adrenal gland tissue, epinephrine, corticotropin, ephedra, licorice root, American ginseng, rose hip fruit, sodium chloride, and zinc. In homeopathic practice, these ingredients are traditionally used to support adrenal function and energy, though homeopathic products are not evaluated by the FDA for effectiveness and are marketed based on homeopathic tradition rather than scientific evidence.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
83027-0014-01 You're viewing this Main listing 120 mL in 1 BOTTLE, GLASS 2023-02-21 Sep 20, 2028 Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Adrenal Liquescence 2 [hp_X]/mL; 3 [hp_X]/mL; 3 [hp_X]/mL; 6 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mLthis 83027-0014-01 Nutritional 120 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Feb 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerNutritional Specialties, Inc.
Labeler code83027
First marketedFeb 2023
Product typeHuman Otc Drug
Portfolio162 products on file

More NDCs from Nutritional Specialties, Inc. labeler code 83027

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 21 words ▾

INDICATIONS: Provides potentized homeo-nutritional support of the adrenal.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

⏱️ Dosage and Administration 30 words ▾

DIRECTIONS: Adults 1 to 2 teaspoons one to two times daily. Children under twelve one half adult dosage. Consult a physician for use in children under 12 years of age.

⚠️ Warnings 59 words ▾

WARNINGS: Professional Use Only If pregnant or breast-feeding, ask a health professional before use. In case of overdose, get medical help or contact a Poison Control Center right away. If condition worsens, seek medical attention. KEEP OUT OF REACH OF CHILDREN Do not use if tamper evident seal is broken or missing. Store in a cool place after opening

🧪 Active Ingredient 28 words ▾

ACTIVE INGREDIENTS: Glycyrrhiza Glabra 2X, Rosa Canina 3X, Aralia Quinquefolia 3X, 6X, Glandula Suprarenalis 6X, Adrenalinum 12X, Ephedra Vulgaris 12X, Natrum Muriaticum 12X, Zincum Metallicum 12X, Adrenocorticotrophin 15C.

🧪 Inactive Ingredients 8 words ▾

INACTIVE INGREDIENTS: Alcohol USP 20%, Purified Water USP.

🎯 Purpose 21 words ▾

PURPOSE: Provides potentized homeo-nutritional support of the adrenal.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

📄 Keep Out of Reach of Children 21 words ▾

KEEP OUT OF REACH OF CHILDREN: In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 14 words ▾

QUESTIONS: MANUFACTURED EXCLUSIVELY FOR NUTRITIONAL SPECIALTIES, INC. PO BOX 97227 PITTSBURG, PA 15229 www.phpltd.com

📄 Package Label / Principal Display Panel 18 words ▾

PACKAGE LABEL DISPLAY: Professional Health Products HOMEOPATHIC NDC 83027-0014-1 ADRENAL LIQUESCENCE 4 FL. OZ (120 ml) ADRENAL LIQUESCENCE

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

Adrenal Liquescence Glycyrrhiza Glabra, Rosa Canina, Aralia Quinquefolia (American Ginseng), Glandula Suprarenalis (Bovine), Adrenalinum, Ephedra Vulgaris, Natrum Muriaticum, Zincum Metallicum, Adrenocorticotrophin 2 [hp_X]/mL; 3 [hp_X]/mL; 3 [hp_X]/mL; 6 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mL; 12 [hp_X]/mL LIQUID is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but Nutritional Specialties, Inc. has reported a marketing end date of 2028-09-20, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
Nutritional Specialties, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.